Beam Therapeutics Inc.
BEAM
$28.79
$2.057.65%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 14.55% | 13.33% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 14.55% | 13.33% | |||
| Cost of Revenue | 7.87% | 2.98% | |||
| Gross Profit | -7.27% | -2.13% | |||
| SG&A Expenses | -0.44% | -3.87% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 6.14% | 1.47% | |||
| Operating Income | -5.54% | -0.73% | |||
| Income Before Tax | -10.20% | 6.39% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -10.20% | 6.39% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -10.20% | 6.39% | |||
| EBIT | -5.54% | -0.73% | |||
| EBITDA | -5.79% | -0.75% | |||
| EPS Basic | -9.58% | 19.26% | |||
| Normalized Basic EPS | -10.23% | 14.13% | |||
| EPS Diluted | -9.58% | 19.26% | |||
| Normalized Diluted EPS | -10.23% | 14.13% | |||
| Average Basic Shares Outstanding | 0.56% | 15.94% | |||
| Average Diluted Shares Outstanding | 0.56% | 15.94% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||